Pharmacy News EU

Investigators publish new data in the report ‘Epidural analgesia for postoperative pain control after adolescent spinal fusion procedures which violated the epidural space.’ According to recent research from the United States, "Retrospective chart review. To determine the effectiveness of epidural analgesia in scoliosis patients with an opened (violated) spinal canal.""Postoperative continuous epidural analgesia using local [...]

Jun 22, 2010 (FinancialWire via COMTEX) (Comment on this article at 22, 2010 (FinancialWire) Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical firm, said it has signed an agreement providing Cadence with an exclusive option to acquire Incline Therapeutics, Inc., a privately held specialty pharmaceutical company. The company also said that it has [...]

SAN DIEGO, June 21 /PRNewswire-FirstCall/ Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that it has signed an agreement providing Cadence with an exclusive option to acquire Incline Therapeutics, Inc., a privately held specialty pharmaceutical company. [...]

REDWOOD CITY, Calif., June 21 /PRNewswire/ Incline Therapeutics, Inc., a privately-held, hospital-focused specialty pharmaceutical company, announced today that it has entered into an agreement to acquire the rights to IONSYS? (fentanyl iontophoretic transdermal system) from ALZA Corporation and completed a $43 million Series A financing.IONSYS? AcquisitionUnder the terms of the agreement, Incline will receive [...]

SAN DIEGO, April 20 /PRNewswire-FirstCall/ A new report from KLAS, an independent health care vendor research firm, concluded the CareFusion (NYSE: CFN) Alaris System is one of the "best all-around" infusion pump options for hospitals, with 99 percent of interviewed customers stating they would repeat their decision and purchase the Alaris System again. For [...]

9 February 2010 – US biotechnology company Cara Therapeutics Inc reported yesterday encouraging data in a Phase II proof-of-concept clinical trial of its peripherally-restricted kappa opioid agonist, CR845.The 46-patient, Phase II, multi-centre, double-blind, placebo-controlled study was conducted at eight hospitals in the US and evaluated the efficacy and safety of CR845 in women following laparoscopic-assisted [...]

SHELTON, Conn., Feb. 8 /PRNewswire/ Cara Therapeutics, Inc. today announced positive data in a Phase II proof-of-concept clinical trial of its peripherally-restricted kappa opioid agonist, CR845. The 46 patient Phase II, multi-center, double-blind, placebo-controlled study was conducted at eight hospitals in the United States and evaluated the efficacy and safety of CR845 in women [...]

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of [...]

2009 NOV 2 – (NewsRx.com) Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced [...]

Dec. 31East Aurora aerospace company Moog Inc. is wrapping up 2008 with a European acquisition. Moog purchased Lithuanian medical device maker, AITECS Medical UAB, for $21 million. AITECS manufactures syringe-style therapy pumps for general use by hospitals, operating rooms and patient-controlled analgesia. In a statement announcing the acquisition, the local company estimated AITECS will add approximately $6 [...]